309 related articles for article (PubMed ID: 28775117)
21. Expression of gelatinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary in relation to follicle development and atresia.
Hrabia A; Wolak D; Kwaśniewska M; Kieronska A; Socha JK; Sechman A
Theriogenology; 2019 Feb; 125():268-276. PubMed ID: 30481606
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical study of matrix metalloproteinases-2 and -9, macrophage inflammatory protein-2 and tissue inhibitors of matrix metalloproteinases-1 and -2 in normal, purulonecrotic and fungal infected equine corneas.
Boveland SD; Moore PA; Mysore J; Krunkosky TM; Dietrich UM; Jarrett C; Paige Carmichael K
Vet Ophthalmol; 2010 Mar; 13(2):81-90. PubMed ID: 20447025
[TBL] [Abstract][Full Text] [Related]
23. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression.
Walther T; Schubert A; Falk V; Binner C; Kanev A; Bleiziffer S; Walther C; Doll N; Autschbach R; Mohr FW
Circulation; 2001 Sep; 104(12 Suppl 1):I54-8. PubMed ID: 11568030
[TBL] [Abstract][Full Text] [Related]
24. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
[TBL] [Abstract][Full Text] [Related]
25. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
Lichtinghagen R; Michels D; Haberkorn CI; Arndt B; Bahr M; Flemming P; Manns MP; Boeker KH
J Hepatol; 2001 Feb; 34(2):239-47. PubMed ID: 11281552
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in tissue remodeling after sealing of the fetal membranes in a sheep model of fetoscopic surgery.
Devlieger R; Riley SC; Verbist L; Leask R; Pijnenborg R; Deprest JA
J Soc Gynecol Investig; 2002; 9(3):137-45. PubMed ID: 12009387
[TBL] [Abstract][Full Text] [Related]
28. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14.
Filanti C; Dickson GR; Di Martino D; Ulivi V; Sanguineti C; Romano P; Palermo C; Manduca P
J Bone Miner Res; 2000 Nov; 15(11):2154-68. PubMed ID: 11092396
[TBL] [Abstract][Full Text] [Related]
29. [Expression of matrix metalloproteinases and their inhibitors in the internal carotid artery wall in pathological tortuosity].
Paltseva EM; Polyakova VO; Oskolkova SA; Abramyan AV; Ivanova AG; Krylova YS; Gavrilenko AV
Arkh Patol; 2016; 78(3):26-31. PubMed ID: 27296003
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
31. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 gp120 upregulates matrix metalloproteinases and their inhibitors in a rat model of HIV encephalopathy.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele EJ; Strayer DS
Eur J Neurosci; 2011 Dec; 34(12):2015-23. PubMed ID: 22092673
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary.
Robinson LL; Sznajder NA; Riley SC; Anderson RA
Mol Hum Reprod; 2001 Jul; 7(7):641-8. PubMed ID: 11420387
[TBL] [Abstract][Full Text] [Related]
34. Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis.
Kouwenhoven M; Ozenci V; Tjernlund A; Pashenkov M; Homman M; Press R; Link H
J Neuroimmunol; 2002 May; 126(1-2):161-71. PubMed ID: 12020967
[TBL] [Abstract][Full Text] [Related]
35. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
36. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct regression and recrudescence.
Leśniak-Walentyn A; Hrabia A
Cell Tissue Res; 2016 Nov; 366(2):443-454. PubMed ID: 27342592
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinases-1 and -2, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients.
Zdzisińska B; Walter-Croneck A; Kandefer-Szerszeń M
Leuk Res; 2008 Nov; 32(11):1763-9. PubMed ID: 18472160
[TBL] [Abstract][Full Text] [Related]
38. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
Tanney DC; Feng L; Pollock AS; Lovett DH
Dev Dyn; 1998 Sep; 213(1):121-9. PubMed ID: 9733107
[TBL] [Abstract][Full Text] [Related]
39. The Activity of Matrix Metalloproteinases (MMP-2, MMP-9) and Their Tissue Inhibitors (TIMP-1, TIMP-3) in the Cerebral Cortex and Hippocampus in Experimental Acanthamoebiasis.
Łanocha-Arendarczyk N; Baranowska-Bosiacka I; Gutowska I; Kolasa-Wołosiuk A; Kot K; Łanocha A; Metryka E; Wiszniewska B; Chlubek D; Kosik-Bogacka D
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572657
[TBL] [Abstract][Full Text] [Related]
40. Differential expression and activity of matrix metalloproteinase-2 and -9 in the calreticulin deficient cells.
Wu M; Massaeli H; Durston M; Mesaeli N
Matrix Biol; 2007 Jul; 26(6):463-72. PubMed ID: 17412577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
